🇺🇸 FDA
Patent

US 6495721

Sertraline hydrochloride Form II and methods for the preparation thereof

expired A61PA61P25/24

Quick answer

US patent 6495721 (Sertraline hydrochloride Form II and methods for the preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Dec 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P25/24